https://www.giampharma.com/a-novel-calix4pyrrole-derivative-as-a-potential-anticancer-agent-that-forms-genotoxic-adducts-with-dna/2025-05-30T10:54:08+02:00https://www.giampharma.com/two-calix4pyrroles-as-potential-therapeutics-for-castration-resistant-prostate-cancer/2025-06-03T16:15:46+02:00https://www.giampharma.com/fraisinib-a-calixpyrrole-derivative-reducing-a549-cell-derived-nsclc-tumor-in-vivo-acts-as-a-ligand-of-the-glycine-trna-synthase-a-new-molecular-target-in-oncology/2025-06-03T16:33:18+02:00